Stockscreener 앱 받기
1.05
5.52%
0.0549
전일 마감가:
$0.9951
열려 있는:
$1
하루 거래량:
677.56K
Relative Volume:
0.21
시가총액:
$23.61M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.1583
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
-9.48%
1개월 성능:
-5.41%
6개월 성능:
+36.29%
1년 성능:
-57.14%
1일 변동 폭
$0.961
$1.07
1주일 범위
$0.961
$1.277
52주 변동 폭
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
IBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.05 | 22.38M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Oppenheimer | Outperform |
| 2025-10-17 | 개시 | Leerink Partners | Outperform |
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
모두보기
iBio Inc 주식(IBIO)의 최신 뉴스
iBio Confirms Directors and Auditor at Annual Meeting - TipRanks
iBio shareholders elect directors and approve annual meeting proposals - Investing.com
How robust is iBio Inc. (0JV0) stock financial position2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Can trapped investors hope for a rebound in iBio Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
iBio, Inc. (IBIO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How iBio Inc. (0JV0) stock responds to job market shiftsJobs Report & Momentum Based Trading Signals - newser.com
Is iBio Inc. stock safe for conservative investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
Why hedge funds are buying iBio Inc. stockJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Will iBio Inc. stock deliver better than expected guidanceMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Why iBio Inc. (0JV0) stock trades below fair valueWeekly Risk Report & Verified Entry Point Signals - newser.com
Is iBio Inc. (0JV0) stock supported by free cash flowJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock is rated strong buyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Why analysts raise outlook for iBio Inc. (0JV0) stock2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock appeals to dividend seekersJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Is iBio Inc. (0JV0) stock a fit for income portfoliosEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Why iBio Inc. (0JV0) stock could be next leaderPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Is iBio Inc. (0JV0) stock a top dividend aristocrat candidate - newser.com
Using AI based signals to follow iBio Inc.2025 Pullback Review & Risk Managed Trade Strategies - newser.com
What high frequency data says about iBio Inc.Quarterly Risk Review & Technical Entry and Exit Tips - newser.com
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Certain Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Prefunded Warrants of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Restricted Stock Units of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
Certain Options of iBio, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2025. - MarketScreener
[8-K] iBio, Inc. Reports Material Event | IBIO SEC FilingForm 8-K - Stock Titan
iBio, Inc. Reports Q3 2025 Financial Results - MSN
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):